MedPath
TGA Approval

ENABLEX darifenacin 7.5mg (as hydrobromide) modified release tablet blister pack (99418)

99418

ENABLEX darifenacin 7.5mg (as hydrobromide) modified release tablet blister pack

Aspen Pharmacare Australia Pty Ltd

March 16, 2005

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-CMI-01704-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-PI-01703-1

Active Ingredients

darifenacin hydrobromide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ENABLEX darifenacin 7.5mg (as hydrobromide) modified release tablet blister pack (99418) - TGA 批准文号 | MedPath